Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Occludin is an integral membrane protein (~65 kDa) localized primarily at the tight junctions between epithelial and endothelial cells. It plays a central role in regulating paracellular permeability by forming part of the physical seal between adjacent cells. Occludin has four transmembrane domains with two extracellular loops critical for cell-cell adhesion. Its cytoplasmic C-terminal domain interacts with scaffolding proteins like ZO‑1/ZO‑2/ZO‑3 and F-actin to anchor it within the cellular architecture. Beyond its structural role at tight junctions, recent evidence suggests that occludin also participates in cell signaling pathways affecting metabolism and gene expression. Disruption or downregulation of occludin contributes to various pathologies involving compromised tissue barriers—including neurological disorders linked to genetic mutations in OCLN—and serves as an essential co-receptor facilitating hepatitis C virus entry into hepatocytes. Multiple isoforms exist due to alternative splicing; post-translational modifications such as phosphorylation regulate its localization/functionality within tissues.
For experimental drugs/agents targeting occludin or its pathway: - Modulation of tight junction integrity/permeability - Inhibition of viral entry by blocking co-receptor function for HCV
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Occludin (OCLN).